Intravenous Neonatal Central Access Safety Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intravenous Neonatal Central Access Safety Trial — Stella

Home/Newborn Complication/

View on ClinicalTrials.gov

Recruiting

Back to Newborn Complication trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Città della Salute e della Scienza, Torino, Italia

Key details

Sponsor

University of Turin, Italy

Collaborators

Pall Corporation

Enrollment target

~736 participants

Started

January 2023

Primary completion

June 2026

Age range

1 Hour – 3 Months

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.